BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang J, Li Q, Zheng Y, Shen J, Li B, Zou R, Wang J, Yuan Y. Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature. BMC Cancer 2014;14:818. [PMID: 25376591 DOI: 10.1186/1471-2407-14-818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Schwarz C, Kaczirek K, Bodingbauer M. Liver resection for non-colorectal metastases. Eur Surg 2018;50:113-6. [PMID: 29875799 DOI: 10.1007/s10353-018-0528-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hu W, Yao W, Li H, Chen L. MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1. Biosci Rep 2020;40:BSR20194309. [PMID: 32458989 DOI: 10.1042/BSR20194309] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Song KA, Faber AC. OVOL2 in metastasis prevention in NPC. Theranostics 2018;8:2242-4. [PMID: 29721076 DOI: 10.7150/thno.25181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liang Y, Sun X, Yang Z, Tang Q, Guo S, Liu L, Xie H, Liu S, Yan J, Li X, Chen Q, Mai H. Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients. Oral Oncology 2019;92:40-5. [DOI: 10.1016/j.oraloncology.2019.03.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Liao W, He J, Gou Q, Duan B, Ai P, Liu L, Li Y, Ren K, Yao M, Chen N. Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma. Head Neck 2021;43:2423-33. [PMID: 33939262 DOI: 10.1002/hed.26706] [Reference Citation Analysis]
6 Liao W, Tian M, Chen N. Characteristic And Novel Therapeutic Strategies Of Nasopharyngeal Carcinoma With Synchronous Metastasis. Cancer Manag Res 2019;11:8431-42. [PMID: 31571998 DOI: 10.2147/CMAR.S219994] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
7 Mat Lazim N, Elliott M, Wykes J, Clark J. Oligometastases in head and neck carcinoma and their impact on management. ANZ J Surg 2021. [PMID: 33634950 DOI: 10.1111/ans.16622] [Reference Citation Analysis]
8 Yang ZC, Luo MJ, Sun XS, Liu LT, Chen QY, Mai HQ, Guo SS. Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study. Head Neck 2022. [PMID: 35146832 DOI: 10.1002/hed.26999] [Reference Citation Analysis]
9 Yang L, Xue Y, Wei Z, Ren K, Liu Z, Chang T, Peng X, Su Y, Li Y. Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: A retrospective cohort study. Head Neck 2021. [PMID: 34962007 DOI: 10.1002/hed.26953] [Reference Citation Analysis]
10 Kurihara T, Itoh S, Kimura Y, Oki E, Yoshizumi T, Matuo M, Yasumatsu R, Sugimachi K, Morita M, Kusumoto T, Fukuzawa K, Yoshida N, Baba H, Mori M. Feasibility of hepatic resection for liver metastasis of head-and-neck carcinoma or esophageal carcinoma: a multi-center experience. Surg Today 2021. [PMID: 34032927 DOI: 10.1007/s00595-021-02305-6] [Reference Citation Analysis]
11 Cammann S, Oldhafer F, Ringe KI, Ramackers W, Timrott K, Kleine M, Klempnauer J, Lehner F, Bektas H, Vondran FWR. Use of the liver maximum function capacity test (LiMAx) for the management of liver resection in cirrhosis - A case of hypopharyngeal cancer liver metastasis. Int J Surg Case Rep 2017;39:140-4. [PMID: 28841541 DOI: 10.1016/j.ijscr.2017.08.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Liu H, Yang P, Jia Y. Optimal management of oligometastatic nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2021. [PMID: 34089384 DOI: 10.1007/s00405-021-06918-y] [Reference Citation Analysis]
13 Toumi N, Ennouri S, Charfeddine I, Daoud J, Khanfir A. Prognostic factors in metastatic nasopharyngeal carcinoma. Braz J Otorhinolaryngol 2020:S1808-8694(20)30092-6. [PMID: 32690385 DOI: 10.1016/j.bjorl.2020.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Liu Q, Wang J, Sun C, Xu J. The diagnosis and management of rare cystic liver metastases from nasopharyngeal carcinoma: A case report. Medicine (Baltimore) 2018;97:e11257. [PMID: 29952994 DOI: 10.1097/MD.0000000000011257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Chua GWY, Chua ET. Long-Term Disease-Free Survival of a Patient with Oligometastatic Nasopharyngeal Carcinoma Treated with Radiotherapy Alone. Case Rep Oncol 2018;11:392-8. [PMID: 30022942 DOI: 10.1159/000490236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Lok HT, Fung AKY, Chong CCN, Lee KF, Wong J, Cheung SYS, Lai PBS, Ng KKC. Comparison of long-term survival outcome after curative hepatectomy between selected patients with non-colorectal and colorectal liver metastasis: A propensity score matching analysis. Asian J Surg 2021;44:459-64. [PMID: 33229125 DOI: 10.1016/j.asjsur.2020.10.019] [Reference Citation Analysis]